alexa A Vaccine Pipeline: Using Phage Display For Identification Of Immunogenic Proteins And Generation Of Human Antibodies For Diagnostics And Therapy
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Vaccines & Vaccination
September 24-26, 2014 Valencia Convention Centre, Spain

Michael Hust
ScientificTracks Abstracts: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.020
T he identification of new immunogenic proteins of pathogens is a prerequisite for development of vaccines and diagnostic assays. We are using phage display to identify novel antigens from bacterial genome libraries. We also developed an antibody generation pipeline. The combination of both phage display based technologies led to a ?vaccine development pipeline?. Here, the technology will be described and examples for the identification of immunogenic proteins of Mycoplasma species and Salmonella Typhimurium as well as examples from our antibody generation and engineering pipeline for pathogens and toxins (botulinum toxins, Venezuelan equine encephalitis virus) will be given.
Michael Hust studied biology at the Carl von Ossietzky Universit?t in Oldenburg, Germany, from 1993-1999. He got his PhD at the Leibniz Universit?t in Hannover, Germany, in 2002. Since end of 2002, he is working as group leader at the Technische Universit?t Braunschweig, Germany, in the Department of Biotechnology. In 2011 he finished his professorial dissertation (Habilitation, venia legendi for Biotechnology) and was appointed as Privatdozent (PD). He has published more than 70 articles (including book chapters and reviews) on antibody engineering and phage display. He cofounded the mAb-Factory GmbH in 2007 and the Yumab GmbH in 2012. He is working on the development of human and human-like antibodies for diagnostics and therapy. Another field of work is the identification of immunogenic proteins of pathogens using phage display
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version